Guides
Travel & medical insurance for treatment abroad
Standard travel insurance may exclude planned treatment and its complications. Disclose the purpose of travel and obtain product-specific written coverage answers before paying or booking.
Tell the insurer that the trip is for planned medical assessment or treatment and describe whether the intervention is authorised, investigational or part of a trial. Incomplete disclosure can affect a claim.
Ask separately about ordinary travel events, cancellation, treatment complications, unrelated illness, extended stay and medical repatriation. One covered category does not imply the others are covered.
A GHIC or EHIC does not fund travel undertaken for planned private treatment. The NHS planned-treatment guide explains the distinction from medically necessary state care during a visit.
Declare relevant pre-existing conditions, medicines and recent changes as the insurer requires. Ask how pending diagnosis or planned tests are treated.
Confirm whether an investigational product, unlicensed use or participation in a clinical trial is excluded. Do not accept a coordinator's assurance about an insurer's policy.
Ask who pays if discharge is delayed or you cannot fly. Include accommodation, companion costs, new tickets and medical escort where relevant.
Check the geographic area, start and end dates, maximum trip length and any requirement to start and finish in the home country. Extend cover before the original period ends if plans change.
Review activity and mobility exclusions for rehabilitation, spa use, sport or tourism after treatment. Follow clinical restrictions even when an activity is insured.
Confirm the emergency-assistance process and whether pre-authorisation is required before non-urgent care. Keep the assistance number and policy details accessible.
Ask whether the insurer can communicate directly with the treating facility and what records are needed. Consent to share only the information necessary for the claim or care.
Read excesses, sublimits and exclusions for private hospitals, experimental treatment, medical devices and repatriation. The headline coverage limit may not apply to every category.
For a trial, also read the sponsor's injury compensation or insurance arrangements. Sponsor cover and travel cover may address different events and neither should be assumed complete.
Keep the itemised treatment quote, appointment confirmation, clinician letters, receipts, discharge summary and incident records. Report events within policy deadlines.
Do not buy a policy solely from a clinic affiliate without comparing scope and conflicts. The provider and insurer should be identifiable legal entities.
If coverage is refused, ask for the decision and policy clause in writing. Consider independent regulated insurance advice when the financial exposure is material.
Build a contingency fund even with insurance, because reimbursement can be delayed and some costs may be excluded. Do not rely on a card limit as the only emergency plan.
Insurance manages specified financial risks; it does not validate the clinic, product, trial or expected outcome. Complete those checks separately.
Use the cost worksheet, then verify the exact product, evidence, legal route and written quotation with an independent qualified clinician.
Sources & further reading
- Stem-cell trials registry (ClinicalTrials.gov) ↗
- Peer-reviewed research (PubMed) ↗
- ISSCR — patient resources ↗
- FDA — consumer guidance ↗
- EMA — ATMP framework ↗
Educational guide; most uses are investigational. Verify the exact product, indication and provider with current regulator records and an independent qualified physician.